Detalles de la búsqueda
1.
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
Eur J Nucl Med Mol Imaging
; 49(12): 4271-4281, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35767071
2.
Lysosome inhibition sensitizes pancreatic cancer to replication stress by aspartate depletion.
Proc Natl Acad Sci U S A
; 116(14): 6842-6847, 2019 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30894490
3.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Lancet Oncol
; 22(8): 1115-1125, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34246328
4.
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774).
Eur Urol
; 86(1): 52-60, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290964
5.
Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
J Nucl Med
; 65(3): 438-445, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238041
6.
FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.
Clin Nucl Med
; 48(7): e353-e355, 2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146173
7.
Presurgical 68Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.
Eur Urol
; 84(6): 588-596, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37482512
8.
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer.
J Nucl Med
; 64(6): 869-872, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635088
9.
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma.
J Nucl Med
; 63(2): 199-204, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272317
10.
18F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue Sarcoma.
J Nucl Med
; 63(5): 708-712, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34593596
11.
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
J Nucl Med
; 63(11): 1651-1658, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35422442
12.
PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study.
J Nucl Med
; 63(1): 76-80, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34620731
13.
A Comprehensive Assessment of 68Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.
J Nucl Med
; 63(4): 567-572, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326126
14.
Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.
J Nucl Med
; 63(6): 847-854, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34649942
15.
Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.
Eur Urol Oncol
; 5(1): 100-103, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602654
16.
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
J Nucl Med
; 63(2): 226-232, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34049987
17.
Update from PSMA-SRT Trial NCT03582774: A Randomized Phase 3 Imaging Trial of Prostate-specific Membrane Antigen Positron Emission Tomography for Salvage Radiation Therapy for Prostate Cancer Recurrence Powered for Clinical Outcome.
Eur Urol Focus
; 7(2): 238-240, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386288
18.
The Impact of Monosodium Glutamate on 68Ga-PSMA-11 Biodistribution in Men with Prostate Cancer: A Prospective Randomized, Controlled Imaging Study.
J Nucl Med
; 62(9): 1244-1251, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509974
19.
Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312).
J Nucl Med
; 62(10): 1447-1456, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34272322
20.
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
JAMA Oncol
; 7(11): 1635-1642, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529005